Compare IRWD & FUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRWD | FUNC |
|---|---|---|
| Founded | 1998 | 1900 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.8M | 262.5M |
| IPO Year | 2010 | N/A |
| Metric | IRWD | FUNC |
|---|---|---|
| Price | $3.55 | $40.70 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.34 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 19.3K |
| Earning Date | 11-10-2025 | 10-20-2025 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ 56.67 |
| EPS | 0.18 | ★ 3.84 |
| Revenue | ★ $338,987,000.00 | $83,662,000.00 |
| Revenue This Year | N/A | $16.22 |
| Revenue Next Year | $4.01 | $7.42 |
| P/E Ratio | $20.22 | ★ $10.61 |
| Revenue Growth | N/A | ★ 17.79 |
| 52 Week Low | $0.53 | $24.66 |
| 52 Week High | $5.13 | $42.50 |
| Indicator | IRWD | FUNC |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 75.66 |
| Support Level | $3.50 | $38.48 |
| Resistance Level | $3.80 | $38.91 |
| Average True Range (ATR) | 0.32 | 0.53 |
| MACD | -0.05 | 0.25 |
| Stochastic Oscillator | 55.49 | 91.31 |
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.